Mangrove Partners Tg Therapeutics, Inc. Transaction History

Mangrove Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $14.1 Million - $18.5 Million	-339,858 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $8.8 Million - $19.1 Million	-348,366 Reduced 50.62%	339,858 $17.7 Million
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $4.93 Million - $12.1 Million	-553,482 Reduced 44.57%	688,224 $13.4 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $8.87 Million - $19.9 Million	1,241,706 New	1,241,706 $12.2 Million

287

91.8M

1.9M

1.45M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.67B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.